Literature DB >> 15446788

Medical phase contrast x-ray imaging: current status and future prospects.

R A Lewis1.   

Abstract

The exploitation of phase contrast appears to offer the tantalising possibility of creating the biggest change in medical x-ray imaging since the invention of computed tomography. A considerable number of experiments performed by researchers across four continents have produced some extraordinary images. These images have demonstrated greatly enhanced contrast over conventional methods revealing soft tissue discrimination at micron scale resolutions. Contrast improvements can be achieved at doses rather less than those required by conventional x-ray imaging. The use of synchrotrons has revealed the possibilities offered by these techniques but unfortunately the application of these ideas in a clinical context requires that technology be pushed to its limits in a number of areas including x-ray sources, optics and detectors. The current state of the art is reviewed.

Mesh:

Substances:

Year:  2004        PMID: 15446788     DOI: 10.1088/0031-9155/49/16/005

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  62 in total

1.  X-ray imaging of poly(ethylene glycol) hydrogels without contrast agents.

Authors:  Eric M Brey; Alyssa Appel; Yu-Chieh Chiu; Zhong Zhong; Ming-Huei Cheng; Holger Engel; Mark A Anastasio
Journal:  Tissue Eng Part C Methods       Date:  2010-07-27       Impact factor: 3.056

2.  Technical Note: Synchrotron-based high-energy x-ray phase sensitive microtomography for biomedical research.

Authors:  Huiqiang Liu; Xizeng Wu; Tiqiao Xiao
Journal:  Med Phys       Date:  2015-10       Impact factor: 4.071

3.  Analytical reconstructions of intensity modulated x-ray phase-contrast imaging of human scale phantoms.

Authors:  Bartłomiej Włodarczyk; Jakub Pietrzak
Journal:  Biomed Opt Express       Date:  2015-10-05       Impact factor: 3.732

4.  High-resolution visualization of airspace structures in intact mice via synchrotron phase-contrast X-ray imaging (PCXI).

Authors:  David W Parsons; Kaye Morgan; Martin Donnelley; Andreas Fouras; Jeffrey Crosbie; Ivan Williams; Richard C Boucher; Kentaro Uesugi; Naoto Yagi; Karen K W Siu
Journal:  J Anat       Date:  2008-08       Impact factor: 2.610

5.  Method for automatization of the alignment of a laboratory based x-ray phase contrast edge illumination system.

Authors:  T P Millard; M Endrizzi; K Ignatyev; C K Hagen; P R T Munro; R D Speller; A Olivo
Journal:  Rev Sci Instrum       Date:  2013-08       Impact factor: 1.523

6.  Phase and absorption retrieval using incoherent X-ray sources.

Authors:  Peter R T Munro; Konstantin Ignatyev; Robert D Speller; Alessandro Olivo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

7.  Development of ultrafast laser-based x-ray in-vivo phase-contrast micro-CT beamline for biomedical applications at Advanced Laser Light Source (ALLS).

Authors:  Russell Kincaid; Andrzej Krol; Sylvain Fourmaux; Jean-Claude Kieffer; Cristina Serbanescu; Marina Servol; Levon Vogelsang; Steve Wilkins; Andrew Stevenson; Yakov Nesterets; Edward Lipson; Hongwei Ye; Andrew Pogany
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-01-01

8.  Quantitative analysis of a micro array anode structured target for hard x-ray grating interferometry.

Authors:  Guibin Zan; David John Vine; Wenbing Yun; Sylvia Jia Yun Lewis; Qiuping Wang; Ge Wang
Journal:  Phys Med Biol       Date:  2020-02-04       Impact factor: 3.609

9.  Phase contrast microradiography of mouse lung using synchrotron X-ray: correlation with optical microscopy.

Authors:  Hwan Seok Yong; Eun-Young Kang; Yoon Kyung Kim; Ok Hee Woo; Bong Kyoung Shin; Chil Hwan Oh; Jung Ho Je; Heon Han; Jae Seung Seo
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

Review 10.  Potential for imaging engineered tissues with X-ray phase contrast.

Authors:  Alyssa Appel; Mark A Anastasio; Eric M Brey
Journal:  Tissue Eng Part B Rev       Date:  2011-08-02       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.